tiprankstipranks
Takara Bio Inc. (JP:4974)
:4974
Japanese Market
4974
Takara Bio Inc.
RESEARCH TOOLSreports
Want to see JP:4974 full AI Analyst Report?

Takara Bio Inc. (4974) Ratios

2 Followers

Takara Bio Inc. Ratios

JP:4974's free cash flow for Q4 2025 was ¥0.51. For the 2025 fiscal year, JP:4974's free cash flow was decreased by ¥ and operating cash flow was ¥0.01. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Mar 25Mar 24Mar 23
Liquidity Ratios
Current Ratio
 5.76 5.76 8.09 8.76 5.40
Quick Ratio
 4.27 4.27 6.34 7.10 4.62
Cash Ratio
 2.63 2.63 4.14 4.63 3.41
Solvency Ratio
 -0.14 -0.14 0.47 0.57 1.24
Operating Cash Flow Ratio
 0.46 0.46 0.82 0.24 2.57
Short-Term Operating Cash Flow Coverage
 17.30 17.30 0.00 9.51 244.35
Net Current Asset Value
¥ 15.19B¥ 15.19B¥ 45.91B¥ 51.34B¥ 60.82B
Leverage Ratios
Debt-to-Assets Ratio
 0.08 0.08 <0.01 <0.01 <0.01
Debt-to-Equity Ratio
 0.11 0.11 <0.01 <0.01 <0.01
Debt-to-Capital Ratio
 0.10 0.10 <0.01 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
 0.09 0.09 0.00 0.00 0.00
Financial Leverage Ratio
 1.29 1.29 1.10 1.10 1.15
Debt Service Coverage Ratio
 -4.38 0.35 279.60 32.30 118.90
Interest Coverage Ratio
 -8.05 -8.05 113.15 130.57 855.88
Debt to Market Cap
 0.07 0.07 0.00 <0.01 <0.01
Interest Debt Per Share
 96.05 96.04 9.31 8.23 8.27
Net Debt to EBITDA
 3.05 -14.96 -4.38 -4.08 -1.85
Profitability Margins
Gross Profit Margin
50.25%50.25%57.88%61.85%57.29%
EBIT Margin
-20.89%-11.63%4.49%6.61%27.19%
EBITDA Margin
-7.70%1.57%14.44%18.16%33.25%
Operating Profit Margin
-11.63%-11.63%5.02%6.90%26.29%
Pretax Profit Margin
-22.82%-22.82%4.43%6.56%27.16%
Net Profit Margin
-23.81%-23.81%2.31%3.40%20.49%
Continuous Operations Profit Margin
-23.69%-23.69%2.41%3.47%20.54%
Net Income Per EBT
104.33%104.33%52.18%51.88%75.44%
EBT Per EBIT
196.25%196.25%88.25%95.00%103.33%
Return on Assets (ROA)
-7.18%-7.18%0.82%1.20%12.39%
Return on Equity (ROE)
-9.22%-9.26%0.90%1.33%14.27%
Return on Capital Employed (ROCE)
-3.72%-3.72%1.88%2.59%17.89%
Return on Invested Capital (ROIC)
-3.72%-3.72%1.02%1.37%13.49%
Return on Tangible Assets
-8.82%-8.82%0.87%1.28%13.33%
Earnings Yield
-6.97%-6.94%1.05%1.27%7.67%
Efficiency Ratios
Receivables Turnover
 3.73 3.73 3.21 3.86 6.28
Payables Turnover
 13.84 13.84 11.48 10.76 14.37
Inventory Turnover
 1.73 1.73 1.53 1.40 3.01
Fixed Asset Turnover
 0.64 0.64 0.79 0.89 1.91
Asset Turnover
 0.30 0.30 0.35 0.35 0.60
Working Capital Turnover Ratio
 1.12 0.92 0.85 0.73 1.37
Cash Conversion Cycle
 282.93 282.93 321.12 321.35 153.98
Days of Sales Outstanding
 97.84 97.84 113.59 94.68 58.14
Days of Inventory Outstanding
 211.46 211.46 239.31 260.60 121.24
Days of Payables Outstanding
 26.37 26.37 31.78 33.93 25.40
Operating Cycle
 309.30 309.30 352.91 355.28 179.39
Cash Flow Ratios
Operating Cash Flow Per Share
 29.75 29.75 48.53 14.21 306.42
Free Cash Flow Per Share
 -74.69 -74.68 -33.44 -91.91 257.57
CapEx Per Share
 104.44 104.43 81.97 106.12 48.85
Free Cash Flow to Operating Cash Flow
 -2.51 -2.51 -0.69 -6.47 0.84
Dividend Paid and CapEx Coverage Ratio
 0.24 0.24 0.49 0.10 3.75
Capital Expenditure Coverage Ratio
 0.28 0.28 0.59 0.13 6.27
Operating Cash Flow Coverage Ratio
 0.33 0.33 5.31 1.77 37.96
Operating Cash Flow to Sales Ratio
 0.09 0.09 0.13 0.04 0.47
Free Cash Flow Yield
-6.53%-6.51%-4.04%-9.51%14.86%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -14.35 -14.40 95.69 78.60 13.03
Price-to-Sales (P/S) Ratio
 3.42 3.43 2.21 2.67 2.67
Price-to-Book (P/B) Ratio
 1.33 1.33 0.86 1.04 1.86
Price-to-Free Cash Flow (P/FCF) Ratio
 -15.32 -15.37 -24.76 -10.51 6.73
Price-to-Operating Cash Flow Ratio
 38.46 38.59 17.06 67.98 5.66
Price-to-Earnings Growth (PEG) Ratio
 0.03 0.01 -3.23 -0.87 -0.67
Price-to-Fair Value
 1.33 1.33 0.86 1.04 1.86
Enterprise Value Multiple
 -41.34 203.43 10.96 10.65 6.18
Enterprise Value
 128.17B 128.77B 71.26B 84.12B 160.59B
EV to EBITDA
 -41.30 203.43 10.96 10.65 6.18
EV to Sales
 3.18 3.19 1.58 1.93 2.06
EV to Free Cash Flow
 -14.25 -14.32 -17.69 -7.60 5.18
EV to Operating Cash Flow
 35.78 35.95 12.19 49.16 4.35
Tangible Book Value Per Share
 657.50 657.47 895.90 861.69 858.78
Shareholders’ Equity Per Share
 860.94 860.89 959.19 926.01 931.94
Tax and Other Ratios
Effective Tax Rate
 -0.04 -0.04 0.46 0.47 0.24
Revenue Per Share
 334.84 334.82 374.03 361.29 648.94
Net Income Per Share
 -79.71 -79.71 8.65 12.29 132.97
Tax Burden
 1.04 1.04 0.52 0.52 0.75
Interest Burden
 1.09 1.96 0.99 0.99 1.00
Research & Development to Revenue
 0.17 0.17 0.15 0.19 0.11
SG&A to Revenue
 0.45 0.45 0.38 0.00 0.00
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 -0.37 -0.37 5.61 1.16 1.74
Currency in JPY